Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration.
2018
Meliani, A., et al. (2018).
Nat Commun 9(1): 4098.
2018
Meliani, A., et al. (2018).
Nat Commun 9(1): 4098.